Related Experiment Video
Updated: Jul 7, 2026
10:32
Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Screening for retinopathy of prematurity
Michael O'Keefe1, Caitriona Kirwan
1The Childrens University Hospital, Temple Street, Dublin, University College Dublin, Ireland. mokeefe@materprivate.ie
Early Human Development
|January 31, 2008
Summary
The CRYO-ROP study confirmed cryotherapy is effective for retinopathy of prematurity (ROP), making screening essential. Early detection and treatment of ROP significantly improve visual outcomes.
Area of Science:
- Ophthalmology
- Neonatology
- Public Health
Background:
- Retinopathy of prematurity (ROP) treatment success confirmed by CRYO-ROP study.
- National screening protocols influenced by ROP incidence variations globally.
- Established screening criteria in developed nations: infants 1000–1500g, 28–31 weeks gestation.
Purpose of the Study:
- To review the impact of CRYO-ROP and ETROP studies on ROP screening and treatment.
- To highlight the importance of updated ROP classifications, including "plus disease."
- To emphasize the critical role of timely screening and early intervention for ROP.
Main Methods:
- Review of findings from key ROP studies (CRYO-ROP, ETROP).
- Analysis of current screening practices and guidelines for preterm infants.
- Discussion of factors influencing national screening policies.
Main Results:
- CRYO-ROP confirmed cryotherapy efficacy and mandated ROP screening.
- ETROP findings led to earlier treatment and increased screening importance.
- Updated classification emphasizes "plus disease" significance.
Conclusions:
- Mandatory screening and early treatment are crucial for improved ROP visual prognosis.
- Neonatal units require agreed screening policies with neonatologist and nurse involvement.
- Future screening may incorporate advanced technologies like diagnostic retinal imaging and telemedicine.
